BlackRock Health Sciences Trust
BMEFinancial ServicesNASDAQAsset Management
Scan Results
Daily timeframeBlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. Valued at $583.0M, BME is a small-cap name in its sector. The fund is managed by BlackRock Advisors, LLC.
Market Cap
$583.0M
Beta
0.60
P/E (TTM)
5.62
P/E (Fwd)
—
EPS (TTM)
$8.03
EPS (Fwd)
—
ROE
19.3%
ROA
0.2%
Cash
$361
Total Debt
$688,351
Free CF
—
52W Change
17.8%
Annual Financials
Cash vs Debt
Where BME stands vs its 150-day and 200-day moving averages
As of the October 19, 2026 close, BME finished 7.50% above its 150-day moving average ($40.94) and 8.43% above its 200-day moving average ($40.59). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is BME overbought or oversold?
At the October 19, 2026 close, BME's RSI(14) was 47.2, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $361 in cash, though total debt stands at $688K. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Return on equity stands at 19.3%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 0.2% is on the lower side, which is common in asset-heavy industries. Revenue has grown from -$26.0M (2022) to $77.5M (2025), reflecting a 399% increase over the period.
BME's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. BlackRock Health Sciences Trust carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for BlackRock Health Sciences Trust and its sector.